The latest AAII Sentiment Survey shows a shift in individual investor outlooks: bullish sentiment increased by 1.0 percentage point to 39.3%, indicating more investors expect stock prices to rise over the next six months. Neutral sentiment dropped by 4.7 points to 24.1%, while bearish sentiment also rose by 3.7 points to 36.6%, reflecting a more polarized market view. This change suggests growing optimism and pessimism among investors, which could influence short-term market dynamics.
DBV Technologies announced a change in its participation at the 47th Annual Global Healthcare Conference by Goldman Sachs, held on June 9, 2026, in Miami. The company's CEO, Daniel Tassé, will not attend the informal discussion as initially planned d...
Revenium introduced AI Insights, a tool that analyzes enterprise AI usage to pinpoint and rank budget waste, linking each issue to specific transactions for easy fixes. This helps companies recover costs by identifying inefficiencies like outdated mo...
Antag Therapeutics has elected Keith Leonard as Chairman of its Board of Directors to support the development of its obesity treatment drug, AT7687. Leonard brings 30 years of biopharmaceutical leadership experience, including roles as CEO and Chairm...
MitoRx Therapeutics has strengthened its leadership team by appointing Alison Strutt as CFO, László Tankó as Consultant CMO, and Sam Fazeli as Non-Executive Director. These hires come as MitoRx prepares to advance its lead drug candidate, MTRX31, a n...
HR Tech 2026, scheduled for October 20-22 in Las Vegas, announced its agenda centered on real-world AI implementation, workforce skills, and HR transformation. The event features sessions from leaders at major companies like IFF, Lumen, and Sanofi, c...
